Characterizing Sleep Problems in 16p11.2 Deletion and Duplication.

Researchers studied sleep problems in people with a specific genetic condition called 16p11.2 deletion or duplication. They looked at 692 people and found that those with this genetic condition had more sleep troubles than typical people, but they slept for the same amount of time. Even family members without the genetic condition had some sleep problems. More research is needed to understand why this happens.

This study examined sleep problems in 692 individuals with 16p11.2 copy number variants (deletions or duplications) using data from the SFARI database. Researchers analyzed sleep questionnaires from 345 youth and 347 adults with these genetic variants. The study found that individuals with 16p11.2 CNVs experienced more sleep disturbances compared to community controls, though sleep duration remained similar. Interestingly, non-carrier family members also showed elevated sleep problems.

The research provides preliminary evidence for sleep difficulties in this specific genetic population associated with neurodevelopmental disorders, though the authors acknowledge that further investigation is needed to better understand these sleep patterns.

Clinicians should screen for sleep problems in individuals with 16p11.2 CNVs and consider family-wide sleep assessments. Sleep interventions may be beneficial for this population, though specific treatment approaches require further research to determine effectiveness.

The study relies on questionnaire data rather than objective sleep measures. The abstract does not specify methodology details or control for potential confounding factors. The authors acknowledge that further studies are needed, suggesting preliminary findings.

Studies of 16p11.2 copy number variants (CNVs) provide an avenue to identify mechanisms of impairment and develop targeted treatments for individuals with neurodevelopmental disorders. 16p11.2 deletion and duplication phenotypes are currently being ascertained; however, sleep disturbances are minimally described. In this study, we examine sleep disturbance in a well-characterized national sample of 16p11.2 CNVs, the Simons Foundation Autism Research Initiative (SFARI) database of youth and adults (n = 692). Factor analyses and multilevel models of derived sleep questionnaires for youth (n = 345) and adults (n = 347) indicate that 16p11.2 carriers show elevated sleep disturbance relative to community controls. Non-carrier family members also show elevated sleep disturbance.

However, sleep duration does not differ between carriers and controls. Further studies of sleep in 16p11.2 are needed.